Anzeige
Mehr »
Login
Montag, 25.10.2021 Börsentäglich über 12.000 News von 675 internationalen Medien
Gamechanger-Meldung, Ausbruch und Indikatoren auf “Strong Buy”
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PharmaTimes

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
14:13Roche launches Foundation Medicine-partnered genomic profiling kit
13:43EC approves Keytruda regimen for triple-negative breast cancer
13:13Rishi Sunak promises £6 billion package for health service
13:13Sajid Javid: NHS likely to have mandatory vaccinations
FrUK doctors: Renewed COVID response is urgent
FrUS approval for J&J and Moderna COVID-19 boosters
FrDupixent hits all endpoints in prurigo nodularis trial
DoNICE recommends gene silencing therapy for porphyria patients on NHS
DoAntengene to collaborate with LegoChem Biosciences for antibody-drug conjugates
MiPsychoactive compound to advance research in treatment of depressive disorders
MiBiotage acquires DNA synthesis and purification company ATDBio
DiScancell gains new facilities at The Oxford Science Park
DiVertex's type 1 diabetes therapy hits the mark in Phase I/II study
DiLovedBy and Dexom announce partnership to aid adolescent patients with diabetes
18.10.NICE approves Ofev for PF-ILD
18.10.MindMaze forms partnership to manufacture brain repair platform for stroke patients
18.10.New asthma drug approved on NHS branded a 'wonder drug'
15.10.Silence Therapeutics announces siRNA collaboration with Hansoh Pharma
15.10.Sensyne Health and OMNY Health sign agreement to support AI research
15.10.NICE clears Opdivo for resected oesophageal or gastro-oesophageal junction cancer
15.10.Phase III trial shows AZ's liver cancer combination improves overall survival
14.10.Entry still open for 2021 Marketer of the Year, Sales and Communications Awards!
14.10.Innovate UK funded NA-ATTC adds three new industry partners
14.10.FDA clears Keytruda for first-line cervical cancer
14.10.NHS publishes new plans to improve patient access to GP appointments